2026 Global: Microwave Ablation Market-Competitive Review (2032) report
Description
The 2026 Global: Microwave Ablation Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Ethicon, a Johnson & Johnson subsidiary based in New Brunswick, United States, commands a leading share in the U.S. microwave ablation market through the NeuWave Microwave Ablation System, widely used for treating liver, kidney, and lung tumors. Boston Scientific, headquartered in Marlborough, United States, markets the Emprint Microwave Ablation System, which has established presence in international markets and is supported by integrated temperature sensing and software analytics. Medtronic, based in Dublin, Ireland, participates in the ablation market by offering compatible microwave generators and disposables that complement its broader interventional oncology portfolio. Lifetech Scientific, headquartered in Shenzhen, China, focuses on cost-effective microwave ablation solutions and leverages regional distribution networks to address demand for hepatic and renal lesion management in Asia. Collectively, these players drive competition through regulatory approvals, clinical education programs, and enhancements to device ergonomics, compatible accessories, and service networks, reinforcing microwave ablation as a scalable modality in oncologic care.
STARmed Co., Ltd., headquartered in Seoul, South Korea, is a recognized regional leader in microwave ablation technology, offering portable and integrated platforms that attract high-volume centers across East Asia. Olympus Corporation, based in Tokyo, Japan, leverages its imaging and endoscopy heritage to support microwave ablation workflows with advanced guidance tools, compatible navigation systems, and a broad array of disposables. Thermo Fisher Scientific, headquartered in Waltham, United States, contributes through its global diagnostics and biomedical research ecosystem, supplying microwave energy generators, monitoring software, and service networks that promote cross-vendor interoperability. Chongqing Haifu Medical Technology, based in Chongqing, China, is a major Asian supplier with a comprehensive microwave ablation line, including controllable energy delivery and applicator arrays, widely used in liver and kidney tumor treatment. Together these firms broaden geographic reach, drive cost competition, and spur variation in device configurations to accommodate diverse hospital settings and operator preferences today across markets worldwide.
AngioDynamics, headquartered in Latham, United States, contributes to microwave ablation deployment through its broad vascular and interventional oncology portfolio, focusing on clinically validated energy delivery platforms and compatible accessories that fit hospital workflows. The company emphasizes procedural efficiency and patient safety, promoting standardized protocols and training programs to integrate microwave ablation into multidisciplinary cancer care. SonaCare Medical, based in Atlanta, United States, concentrates on consumer-friendly, adaptable microwave ablation solutions with modular applicators and energy generators designed for liver and kidney lesions, and it actively collaborates with hospitals to disseminate best practices and post-market surveillance. Together with the earlier players, AngioDynamics and SonaCare complete a ten-company landscape that spans North America, Europe, and Asia, providing clinicians with choices in energy sources, applicator geometries, and software interfaces. The resulting competitive dynamics support continued clinical validation, refined reimbursement strategies, and accelerated adoption of microwave ablation as a minimally invasive option for solid tumors.
Ethicon, a Johnson & Johnson subsidiary based in New Brunswick, United States, commands a leading share in the U.S. microwave ablation market through the NeuWave Microwave Ablation System, widely used for treating liver, kidney, and lung tumors. Boston Scientific, headquartered in Marlborough, United States, markets the Emprint Microwave Ablation System, which has established presence in international markets and is supported by integrated temperature sensing and software analytics. Medtronic, based in Dublin, Ireland, participates in the ablation market by offering compatible microwave generators and disposables that complement its broader interventional oncology portfolio. Lifetech Scientific, headquartered in Shenzhen, China, focuses on cost-effective microwave ablation solutions and leverages regional distribution networks to address demand for hepatic and renal lesion management in Asia. Collectively, these players drive competition through regulatory approvals, clinical education programs, and enhancements to device ergonomics, compatible accessories, and service networks, reinforcing microwave ablation as a scalable modality in oncologic care.
STARmed Co., Ltd., headquartered in Seoul, South Korea, is a recognized regional leader in microwave ablation technology, offering portable and integrated platforms that attract high-volume centers across East Asia. Olympus Corporation, based in Tokyo, Japan, leverages its imaging and endoscopy heritage to support microwave ablation workflows with advanced guidance tools, compatible navigation systems, and a broad array of disposables. Thermo Fisher Scientific, headquartered in Waltham, United States, contributes through its global diagnostics and biomedical research ecosystem, supplying microwave energy generators, monitoring software, and service networks that promote cross-vendor interoperability. Chongqing Haifu Medical Technology, based in Chongqing, China, is a major Asian supplier with a comprehensive microwave ablation line, including controllable energy delivery and applicator arrays, widely used in liver and kidney tumor treatment. Together these firms broaden geographic reach, drive cost competition, and spur variation in device configurations to accommodate diverse hospital settings and operator preferences today across markets worldwide.
AngioDynamics, headquartered in Latham, United States, contributes to microwave ablation deployment through its broad vascular and interventional oncology portfolio, focusing on clinically validated energy delivery platforms and compatible accessories that fit hospital workflows. The company emphasizes procedural efficiency and patient safety, promoting standardized protocols and training programs to integrate microwave ablation into multidisciplinary cancer care. SonaCare Medical, based in Atlanta, United States, concentrates on consumer-friendly, adaptable microwave ablation solutions with modular applicators and energy generators designed for liver and kidney lesions, and it actively collaborates with hospitals to disseminate best practices and post-market surveillance. Together with the earlier players, AngioDynamics and SonaCare complete a ten-company landscape that spans North America, Europe, and Asia, providing clinicians with choices in energy sources, applicator geometries, and software interfaces. The resulting competitive dynamics support continued clinical validation, refined reimbursement strategies, and accelerated adoption of microwave ablation as a minimally invasive option for solid tumors.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
